GLP-1 agonist use in early pregnancy linked to gestational weight gain and complications #GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders in a cohort mainly composed of women with #obesity
Lifestyle A good weight loss programme will prioritise a diet rich in nutritious food, good sleep and minimal alcohol consumption, as well as calorie reduction
5 Swirl gently: Roll between your palms
Efficacy and Safety of Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist, in People with Type 2 Diabetes and Inadequate Glycaemic Control with Diet and Exercise (TRANSCEND-T2D-1): A Double-Blind, Randomised, Phase 3 Trial
Safety and Legal Considerations in Charleston, SC Peptide therapy must be approached responsibly
For many women, thats simply not realistic